longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Novo Nordisk AS

NVO

42.5302.12% ( -0.920 )
Closed: Sep 15, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 10.62, below the reasonable range, cheaper than 80.84% of the time in the past 1 years, and the industry ranks 12/257, the industry Median -1.28.

10.62xP/E
$43.45Stock price
$4.09Earnings per share
10.62xP/E
Stock price$43.45Earnings per share$4.09

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
11.56x
Typical range
10.64x–14.72x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
NVOUSNovo Nordisk AS
10.62x7.16%$192.17B
BMYUSBristol Myers Squibb
14.11x62.25%$130.94B
GSKUSGSK
15.82x6.56%$101.99B
UCBJYUSUCB S.A.
18.18x--$46.30B
HLNUSHaleon
19.06x2.92%$41.36B
OTSKYUSOtsuka Pharmaceutical
14.83x--$38.40B
DSNKYUSDaiichi Sankyo
19.95x--$33.50B
ZTSUSZoetis
11.54x6.81%$30.44B
ALPMYUSAstellas Pharma
11.42x--$26.63B
JAZZUSJazz Pharma
16.97x349.11%$15.96B
OPHLYUSOno Pharmaceutical
14.51x--$7.07B
INDVUSIndivior Pharmaceuticals
11.43x126.83%$4.07B
SNPHYUSSanten Pharmaceutical
14.54x--$3.59B
OGNUSOrganon
17.15x211.11%$3.58B
HRMYUSHarmony Biosciences
13.35x45.48%$2.42B
PBHUSPrestige Brands
13.12x7.48%$2.26B
GTBIFUSGreen Thumb Industries Inc.
13.36x--$1.69B
ANIPUSANI Pharma
15.88x49.55%$1.58B
PAHCUSPhibro Animal Health
14.63x26.75%$1.46B
OMERUSOmeros
10.13x1,880.00%$1.26B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.